Dupont Capital Management Corp Iovance Biotherapeutics, Inc. Transaction History

Dupont Capital Management Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	BUY	$9.53 - $13.11 $82,110 - $112,955	8,616 New	8,616 $83,000
Q1 2021 Apr 29, 2021	SELL	$28.67 - $52.59 $139,594 - $256,060	-4,869 Closed	0 $0
Q3 2020 Oct 29, 2020	SELL	$27.75 - $36.3 $409,534 - $535,715	-14,758 Reduced 75.19%	4,869 $160,000
Q2 2020 Jul 24, 2020	SELL	$27.21 - $41.0 $13,441 - $20,254	-494 Reduced 2.46%	19,627 $539,000
Q1 2020 Apr 29, 2020	SELL	$19.54 - $38.85 $104,578 - $207,925	-5,352 Reduced 21.01%	20,121 $602,000
Q4 2019 Jan 27, 2020	BUY	$17.95 - $29.41 $457,240 - $749,160	25,473 New	25,473 $705,000
Q2 2019 Jul 30, 2019	SELL	$9.78 - $24.52 $370,368 - $928,572	-37,870 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$7.51 - $11.93 $74,596 - $118,500	9,933 Added 35.55%	37,870 $335,000
Q3 2018 Nov 05, 2018	BUY	$11.25 - $17.7 $314,291 - $494,484	27,937 New	27,937 $314,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.